SAN DIEGO, Jan. 31, 2012 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) ("REVA" or the "Company") is pleased to announce that representatives of the Company will present at two upcoming scientific conferences. Dr. Greg Kaluza, Director of Research for the Skirball Center for Cardiovascular Research in New York, will present at the LDDR 2012 Conference on February 3, 2012 at 1:45 p.m. CET. The conference is being held at the Mandarin Oriental Hotel in Geneva Switzerland. Dr. Alexandre Abizaid, principal investigator for REVA's RESTORE clinical trial, will present at the Cardiovascular Research Technologies ("CRT 2012") Conference on February 6, 2012 at 1:45 p.m. US EST. The conference is being held at the Omni Shoreham Hotel in Washington DC.
